TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB02505

Activity

Antibacterial Anticancer Hemolysis Toxicity

Activity_category_statistics

Anti-infective peptides Cancer-related peptides Toxicity and safety peptides

Database_Source

AntiBP3 Peptipedia HemoPI Hemolytic2 PD_Hemolysis

Sequence_Type

standard

Has_Modification No

Description A 10-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, HemoPI, and other sources, with an available 3D structural model.

Sequence

LLLLKFKKLQ

FASTA

>TPDB02505|Antibacterial;Anticancer;Hemolysis;Toxicity|length=10
LLLLKFKKLQ

Formula C62H110N14O12

Absent Amino Acids ARNDCEGHIMPSTWYV

Common Amino Acids L

Mass 1243.64

PI 10.84

Basic Residues 3

Acidic Residues 0

Hydrophobic Residues 6

Net Charge +3

Boman Index -0.38

Hydrophobicity 0.660

Aliphatic Index 195.00

Half Life

Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min

Extinction Coefficient Cystines 0

Absorbance 280nm 0.00

Polar Residues 1

number

0

A

0

R

0

N

0

D

0

C

0

E

1

Q

0

G

0

H

0

I

5

L

3

K

0

M

1

F

0

P

0

S

0

T

0

W

0

Y

0

V

Amino Acid Distribution

A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 0 H: 0 I: 0 L: 5 K: 3 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0

Length

10

Formula

C62H110N14O12

Mass

1243.64

PI

10.84

Net Charge

+3

Boman Index

-0.38

Hydrophobicity

0.660

Evidence 1 Activity

Activity

Activity Endpoint % Hemolysis

Detail Source Activity Hemolysis

Activity Measurement 11.7 %

Hemolysis Raw

Human erythrocytes: 71 ± 11.7% Hemolysis=375 µM

Target

RBC Target Human erythrocytes

Source & Reference

Database Source Hemolytik PD_Hemolysis

Source DRAMP4

Reference

Peptides. 2010 Nov 31(11):2017-26

Other

Source Activity Label	Source Definition
Hemolysis	Hemolytik experimentally validated hemolytic peptide annotation.

Evidence 2 Activity

Activity

Activity Endpoint 71% Hemolysis

Detail Source Activity Toxicity

Activity Measurement 375 µM

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

71% Hemolysis | 375 | µM | target cell: Human erythrocytes

Target

Target Cell Human erythrocytes

Source & Reference

Database Source NA

Source Database DBAASP

Evidence 3 Activity

Activity

Activity Endpoint % Hemolysis

Detail Source Activity Toxicity

Activity Measurement 11.7 %

Toxicity Type Hemolytic Cytotoxic

Toxicity Raw

Hemolytic_activity: Human erythrocytes: 71 ± 11.7% Hemolysis=375 µM | Cytotoxicity: Not available

Target

Target Cell erythrocytes

Source & Reference

Database Source NA

Source Database DRAMP

Reference

Peptides. 2010 Nov 31(11):2017-26

Evidence 4 Hemolysis

Activity

Activity Measurement 11.7 %

Activity Endpoint % Hemolysis

Hemolysis Raw

Human erythrocytes: 71 ± 11.7% Hemolysis=375 µM

Detail Source Activity Hemolysis

Target

RBC Target Human erythrocytes

Source & Reference

source HemoPI PD_Hemolysis

Reference

Peptides. 2010 Nov 31(11):2017-26

Source DRAMP4

Database Source PD_Hemolysis